The institute has started the trial run for the general public and vaccinated 471 people. In April, the vaccine received emergency use authorisation in India, making it the third vaccine to be made available in the country against COVID-19.from News-Economic Times https://ift.tt/3A4C0C9
0 Comments:
Post a Comment